Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

ImmunoGen, Inc. ikhonkco yemakethe

Umthamo wokuthengwa kweempahla ImmunoGen, Inc. namhlanje kunye nembali yentlawulo ye-ImmunoGen, Inc. ukususela ekuqaleni kokuthengisa kwiIMGN izabelo kwi-stock exchange.
Yongeza kumajethijethi
Ukongezwa kumajethi

ImmunoGen, Inc. i-capital capital

Namhlanje i-market capital ImmunoGen, Inc. ingu-2 778 400 256 US dollar.
-40 534 528 $ (-1.44%)
utshintsho lwentengo ukususela ngezolo

Utshintsho kwi-capitalisation yentengiso ye ImmunoGen, Inc. iwebhusayithi yethu ibamba kanye ngosuku. ImmunoGen, Inc. capitalise yeyona nto iyonke ImmunoGen, Inc. iikowuti ezikhutshiweyo zikhutshiwe. Iwebhusayithi yethu ithatha ulwazi lwe-ImmunoGen, Inc. eyongameleyo yanamhlanje kwimithombo evulekile. ImmunoGen, Inc., i-capitalisation - 2 778 400 256 iidola zaseMelika.

ImmunoGen, Inc. ivolumu yezorhwebo

Namhlanje inani lemali yokuthengisa ImmunoGen, Inc. lingama-2 547 501 US dollar.
-90 981 138 $ (-97.28%)
utshintsho lwendleko yorhwebo ukususela ngezolo

ImmunoGen, Inc. ithengiswa kuthengiso lweevenkile ezahlukeneyo. Itshathi yemihla ngemihla yokurhweba ye ImmunoGen, Inc. ikwiwebhusayithi yethu. ImmunoGen, Inc. ukurhweba kwi-intanethi okuthengiswa kwiimarike ezininzi zesitokhwe, sibonisa umthamo opheleleyo ImmunoGen, Inc. ngosuku. ImmunoGen, Inc. itekhs yentengiso yehle nge $ -40 534 528.

Bonisa:
Ukuze

ImmunoGen, Inc. istatshi yekhredithi yemakethe

ImmunoGen, Inc. capitalisation kwigrafu ngeminyaka. 195.82% - utshintsho olwenziwayo kwi-capital capital ye ImmunoGen, Inc. ngeveki. 0 % ngonyaka - utshintsho kwimali eyinkunzi ImmunoGen, Inc.. Iimali yentengiso enkulu ye ImmunoGen, Inc. ngoku ilingana nayo 2 778 400 256 iidola zaseMelika.

Iveki Inyanga iinyanga 3 Unyaka Iminyaka emithathu

ImmunoGen, Inc. imbali yenkxaso-mali

Umhla Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
04/05/2023 2 778 400 256 $
03/05/2023 2 818 934 784 $
02/05/2023 1 275 034 752 $
01/05/2023 1 234 568 320 $
28/04/2023 1 220 648 448 $
27/04/2023 957 304 832 $
26/04/2023 939 221 184 $

ImmunoGen, Inc. isatifiketi somqulu

Iveki Inyanga iinyanga 3 Unyaka Iminyaka emithathu

ImmunoGen, Inc. idatha yembali yevolumu

Umhla Umqulu (24h)
Ixabiso lezorhwebo leImmunoGen, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-IMGN ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
04/05/2023 2 547 501 $
03/05/2023 93 528 639 $
02/05/2023 1 469 949 $
01/05/2023 7 199 139 $
28/04/2023 12 904 809 $
27/04/2023 56 292 $
26/04/2023 1 232 775 $

04/05/2023 ImmunoGen, Inc. capitalised eyi- 2 778 400 256 iidola zaseMelika. Iimali yentengiso enkulu ye ImmunoGen, Inc. kwi 03/05/2023 ifikelele kuthi 2 818 934 784 iidola zaseMelika. Iimali yentengiso enkulu ye ImmunoGen, Inc. kwi 02/05/2023 ifikelele kuthi 1 275 034 752 iidola zaseMelika. ImmunoGen, Inc. capitalisation yimali eyi- $ 1 234 568 320 kwi 01/05/2023.

ImmunoGen, Inc. capitalised eyi- 1 220 648 448 Iidola zaseMelika ku- 28/04/2023. 27/04/2023 ImmunoGen, Inc. capitalised eyi- 957 304 832 iidola zaseMelika. ImmunoGen, Inc. capitalization e 26/04/2023 ifikelele kuthi 939 221 184 iidola zaseMelika.

Inkcitho ye-ImmunoGen, Inc. namhlanje ngu-2 778 400 256 $. Iimali zentengiso ye-ImmunoGen, Inc. ishintshile -1.438% xa kuthelekiswa nezolo. Imali yokuthengisa ye IMGN izabelo ze ImmunoGen, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-2 547 501 $. Ixabiso lokuthengiswa kwezabelo ze ImmunoGen, Inc. latshintshile kwi--97.276% xa kuthelekiswa nosuku lwangaphambili lworhwebo.

Iindleko zezabelo ImmunoGen, Inc.

YezeMali ImmunoGen, Inc.